Focus Partners Advisor Solutions’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Focus Partners Advisor Solutions's NVS Position: Q2 2026 in Review
Focus Partners Advisor Solutions increased its Novartis (NVS) stake by 5.4% in Q2 2026, buying an estimated $57.3K and bringing the position to 7,504 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #521.
Focus Partners Advisor Solutions first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Focus Partners Advisor Solutions held 7,504 shares of Novartis worth $1.18M as of Q2 2026.
- Focus Partners Advisor Solutions bought 382 Novartis shares in Q2 2026, an estimated $57.3K.
- Novartis made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #521 holding.
- Focus Partners Advisor Solutions first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.